leupeptins and Diabetic-Retinopathy

leupeptins has been researched along with Diabetic-Retinopathy* in 2 studies

Other Studies

2 other study(ies) available for leupeptins and Diabetic-Retinopathy

ArticleYear
Proteotoxic Stress Desensitizes TGF-beta Signaling Through Receptor Downregulation in Retinal Pigment Epithelial Cells.
    Current molecular medicine, 2017, Volume: 17, Issue:3

    Proteotoxic stress and transforming growth factor (TGFβ)- induced epithelial-mesenchymal transition (EMT) are two main contributors of intraocular fibrotic disorders, including proliferative vitreoretinopathy (PVR) and proliferative diabetic retinopathy (PDR). However, how these two factors communicate with each other is not well-characterized.. The aim was to investigate the regulatory role of proteotoxic stress on TGFβ signaling in retinal pigment epithelium.. ARPE-19 cells and primary human retinal pigment epithelial (RPE) cells were treated with proteasome inhibitor MG132 and TGFβ. Cell proliferation was analyzed by CCK-8 assay. The levels of mesenchymal markers α-SMA, fibronectin, and vimentin were analyzed by real-time polymerase chain reaction (PCR), western blot, and immunofluorescence. Cell migration was analyzed by scratch wound assay. The levels of p-Smad2, total Smad2, p-extracellular signal-regulated kinase 1/2 (ERK1/2), total ERK1/2, p-focal adhesion kinase (FAK), and total FAK were analyzed by western blot. The mRNA and protein levels of TGFβ receptor-II (TGFβR-II) were measured by realtime PCR and western blot, respectively.. MG132-induced proteotoxic stress resulted in reduced cell proliferation. MG132 significantly suppressed TGFβ-induced upregulation of α-SMA, fibronectin, and vimentin, as well as TGFβ-induced cell migration. The phosphorylation levels of Smad2, ERK1/2, and FAK were also suppressed by MG132. Additionally, the mRNA level and protein level of TGFβR-II decreased upon MG132 treatment.. Proteotoxic stress suppressed TGFβ-induced EMT through downregulation of TGFβR-II and subsequent blockade of Smad2, ERK1/2, and FAK activation.

    Topics: Cell Movement; Cell Proliferation; Diabetic Retinopathy; Epithelial-Mesenchymal Transition; Focal Adhesion Kinase 1; Gene Expression Regulation; Humans; Leupeptins; MAP Kinase Signaling System; Primary Cell Culture; Proteasome Endopeptidase Complex; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Retinal Pigment Epithelium; Smad2 Protein; Transforming Growth Factor beta; Vitreoretinopathy, Proliferative

2017
UPP mediated Diabetic Retinopathy via ROS/PARP and NF-κB inflammatory factor pathways.
    Current molecular medicine, 2015, Volume: 15, Issue:8

    Diabetic retinopathy (DR) is a leading cause of blindness in adults at working age. Human diabetic retinopathy is characterized by the basement membrane thick, pericytes loss, microaneurysms formation, retina neovascularization and vitreous hemorrhage. To investigate whether UPP activated ROS/PARP and NF-κB inflammatory factor pathways in Diabetic Retinopathy, human retinal endothelial cells (HRECs) and rats with streptozotocin-induced diabetes were used to determine the effect of UPP on ROS generation, cell apoptosis, mitochondrial membrane potential (ΔΨm) and inflammatory factor protein expression, through flow cytometry assay, immunohistochemistry, Real-time PCR, Western blot analysis and ELISA. The levels of ROS and apoptosis and the expressions of UPP (Ub and E3) and inflammatory factor protein were increased in high glucose-induced HRECs and retina of diabetic rats, while ΔΨm was decreased. The UPP inhibitor and UbshRNA could attenuate these effects through inhibiting the pathway of ROS/PARP and the expression of NF-κB inflammatory factors, and the increased UPP was a result of high glucose-induced increase of ROS generation and NF-κBp65 expression, accompanied with the decrease of ΔΨm. Clinical study showed the overexpression of UPP and detachment of epiretinal membranes in proliferative DR (PDR) patients. It has been indicated that the pathogenic effect of UPP on DR was involved in the increase of ROS generation and NF-κB expression, which associated with the ROS/PARP and NF-κB inflammatory factor pathways. Our study supports a new insight for further application of UPP inhibitor in DR treatment.

    Topics: Animals; Apoptosis; Cytokines; Diabetic Retinopathy; Disease Models, Animal; Endothelial Cells; Glucose; Humans; Inflammation Mediators; Leupeptins; Male; Membrane Potential, Mitochondrial; NF-kappa B; Poly(ADP-ribose) Polymerases; Proteasome Endopeptidase Complex; Rats; Reactive Oxygen Species; Retinal Pigment Epithelium; RNA, Small Interfering; Signal Transduction; Ubiquitin

2015